Navigation Links
Exposure to CT Scan Radiation may Be Equivalent to That of Nuclear Bomb

Experts at the American College of Radiologists have warned doctors against exposing patients to CT scans unnecessarily because the use of X-ray technology increases the risk of cancer.

They suggest that the amount of radiation that patients are exposed to during CT scans may in some cases be equivalent to that received by some survivors of the Hiroshima and Nagasaki atomic bombs.

According to some estimates, the radiation exposure a patient receives from a full-body CT scan is often 500 times that of a conventional X-ray and about the same as that received by people living 2.4 kilometres away from the centres of the World War II atomic blasts in Japan.

The researchers say that a CT scan might increase a person's risk of cancer by about 0.05 per cent, although experts stress that on average a person's lifetime risk of cancer is about 20 per cent.

They, however, agree that correct use of such scans can save lives.

A report compiled by the institution recommends that medical students should receive mandatory training on the use of CT scans.

It also stressed the need of conveying the risks of the scanning techniques to the public.

"We're concerned and we're aware of it," New Scientist quoted Arl Van Moore, chair of the ACR, as saying.




'"/>




Page: 1

Related medicine news :

1. Exposure to EMF may cause leukemia
2. Exposure To Tobacco Smoke Can Lead To Sickle Cell Crisis
3. Radiation Exposure Found To Affect Intellect Later In Life
4. Cancer Risk From Exposure To Diagnostic X-Rays
5. Limiting Infants Exposure To Smoke At Home
6. Exposure To Night Light may Increase The Risk Of Leukemia
7. Understanding The Harmful Effects Of Radiation Exposure
8. Asbestos Exposure Associated With An Increased Risk For Autoimmune Disease
9. Low dose Radiation Exposure May Cause Cancer
10. Exposure to cigarette smoke when in the womb can lead to asthma
11. Exposure to Pesticides in Schools Produces Illnesses Among Employees, Students
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2017)... VA (PRWEB) , ... March 27, 2017 , ... ... application containerization, today announced it will co-exhibit with technology partners LG Business Solutions ... at the Marriott Metro Center in Washington D.C., will provide education and examination ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... the CE Certificate of Conformity for the Smart System® 20/20. CE Certification builds ... highest industry standards and specifications such as ANSI, ISO and proven test methods ...
(Date:3/27/2017)... ... 2017 , ... Osteitis pubis may be commonplace and seemingly ... occurs when the muscles around the pelvis become inflamed. Over time, untreated osteitis ... as well as accompanying tenderness and weakness. Without proper intervention, it can hinder ...
(Date:3/27/2017)... ... March 27, 2017 , ... EpiGentek , a Farmingdale, ... recent RNA methylation “gold rush” with their established portfolio of optimized assay kits ... N6-methyladenosine, or m6A , RNA methylation has received a new burst in ...
(Date:3/27/2017)... San Mateo, CA (PRWEB) , ... March 27, 2017 , ... Janet Schloz is still ... one of the best days I’ve had in a long time,” she said. , She ... a lot of money that I never thought I would have to help my students.” ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... Pulmatrix, Inc . (NASDAQ: PULM), a clinical stage biopharmaceutical company ... announced that it has added two experts in the fields ... Scientific Advisory Board . The two experts ... MD, former chief of the Pediatric Pulmonary and Allergy Divisions ... University, and David Denning , MD, ...
(Date:3/27/2017)... SAN FRANCISCO , March 27, 2017 ...  is expected to reach USD 16.0 billion by 2025, ... Inc. The growing prevalence of chronic diseases is anticipated ... clinical chemistry analyzers, which thereby widens the scope for ... of geriatric and bariatric population, which is highly susceptible ...
(Date:3/27/2017)... DUBLIN and BOSTON ... AGN), a leading global pharmaceutical company and Paratek ... on the development and commercialization of innovative therapies ... Phase 3 trials of sarecycline for the treatment ... week primary efficacy endpoints. Sarecycline is a once-daily, ...
Breaking Medicine Technology: